NICE, SIGN and RCGP set out further details about the UK guideline on management of the long-term effects of COVID-19

Scope, which defines post-COVID syndrome (Long COVID) as signs and symptoms that develop during or following an infection consistent with COVID-19 which continue for more than 12 weeks and are not explained by an alternative diagnosis, outlines what areas the guideline will cover

SPS commentary:

Areas covered will include, among other things, what symptoms or signs should prompt a referral for specialist assessment or management, what pharmacological and non-pharmacological interventions improve physical or mental health symptoms following acute COVID-19, and how best to deliver post-COVID syndrome recovery and rehabilitation services.

Source:

National Institute for Health and Care Excellence

Resource links:

Press release